Rating History for Amylin Pharmaceuticals (AMLN) by MKM Partners

More Stocks Rated by MKM Partners | Latest Ratings for AMLN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/29/2012 N/A Upgrade Neutral
(N/A)		 22.00
(N/A)		 23.77
(30.98)		 30.33% Details